Biomarker qual

WHO: CDER

WHAT:  To facilitate drug development process by  supporting  regulatory qualification of  biomarker for a particular context of use

WHY: 

  • Provide framework for development and regulatory acceptance
  • Facilitate integration into regulatory review
  • Encourage identification of new and emerging biomarkers
  • Support outreach to stakeholders

HOW: Submit biomarker for qualification

LINK

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s